Click for best price
Gastrointestinal OTC Drugs Market Size, Share 2023
Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal OTC Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal OTC Drugs. This report contains market size and forecasts of Gastrointestinal OTC Drugs in global, including the following market information:
Global Gastrointestinal OTC Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Gastrointestinal OTC Drugs Market Sales, 2018-2023, 2024-2029, (K Dose)
Global top five Gastrointestinal OTC Drugs companies in 2022 (%)
The global Gastrointestinal OTC Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Laxatives Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gastrointestinal OTC Drugs include GlaxoSmithKline, Pfizer, Johnson & Johnson, Bayer, Procter & Gamble, Perrigo, Abbott, Sanofi and Teva Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gastrointestinal OTC Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastrointestinal OTC Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Dose)
Global Gastrointestinal OTC Drugs Market Segment Percentages, by Type, 2022 (%)
Laxatives
Anti-Flatulents
H2-Antaginists
Anti-Diarrheals
PPIs
Anti-Emetics
Other
Global Gastrointestinal OTC Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Dose)
Global Gastrointestinal OTC Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Gastrointestinal OTC Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Dose)
Global Gastrointestinal OTC Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastrointestinal OTC Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gastrointestinal OTC Drugs revenues share in global market, 2022 (%)
Key companies Gastrointestinal OTC Drugs sales in global market, 2018-2023 (Estimated), (K Dose)
Key companies Gastrointestinal OTC Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastrointestinal OTC Drugs, market overview.
Chapter 2: Global Gastrointestinal OTC Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Gastrointestinal OTC Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastrointestinal OTC Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gastrointestinal OTC Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Gastrointestinal OTC Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gastrointestinal OTC Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastrointestinal OTC Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastrointestinal OTC Drugs Overall Market Size
2.1 Global Gastrointestinal OTC Drugs Market Size: 2022 VS 2029
2.2 Global Gastrointestinal OTC Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Gastrointestinal OTC Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Gastrointestinal OTC Drugs Players in Global Market
3.2 Top Global Gastrointestinal OTC Drugs Companies Ranked by Revenue
3.3 Global Gastrointestinal OTC Drugs Revenue by Companies
3.4 Global Gastrointestinal OTC Drugs Sales by Companies
3.5 Global Gastrointestinal OTC Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gastrointestinal OTC Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gastrointestinal OTC Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastrointestinal OTC Drugs Players in Global Market
3.8.1 List of Global Tier 1 Gastrointestinal OTC Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastrointestinal OTC Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastrointestinal OTC Drugs Market Size Markets, 2022 & 2029
4.1.2 Laxatives
4.1.3 Anti-Flatulents
4.1.4 H2-Antaginists
4.1.5 Anti-Diarrheals
4.1.6 PPIs
4.1.7 Anti-Emetics
4.1.8 Other
4.2 By Type - Global Gastrointestinal OTC Drugs Revenue & Forecasts
4.2.1 By Type - Global Gastrointestinal OTC Drugs Revenue, 2018-2023
4.2.2 By Type - Global Gastrointestinal OTC Drugs Revenue, 2024-2029
4.2.3 By Type - Global Gastrointestinal OTC Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Gastrointestinal OTC Drugs Sales & Forecasts
4.3.1 By Type - Global Gastrointestinal OTC Drugs Sales, 2018-2023
4.3.2 By Type - Global Gastrointestinal OTC Drugs Sales, 2024-2029
4.3.3 By Type - Global Gastrointestinal OTC Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Gastrointestinal OTC Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastrointestinal OTC Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Gastrointestinal OTC Drugs Revenue & Forecasts
5.2.1 By Application - Global Gastrointestinal OTC Drugs Revenue, 2018-2023
5.2.2 By Application - Global Gastrointestinal OTC Drugs Revenue, 2024-2029
5.2.3 By Application - Global Gastrointestinal OTC Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Gastrointestinal OTC Drugs Sales & Forecasts
5.3.1 By Application - Global Gastrointestinal OTC Drugs Sales, 2018-2023
5.3.2 By Application - Global Gastrointestinal OTC Drugs Sales, 2024-2029
5.3.3 By Application - Global Gastrointestinal OTC Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Gastrointestinal OTC Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Gastrointestinal OTC Drugs Market Size, 2022 & 2029
6.2 By Region - Global Gastrointestinal OTC Drugs Revenue & Forecasts
6.2.1 By Region - Global Gastrointestinal OTC Drugs Revenue, 2018-2023
6.2.2 By Region - Global Gastrointestinal OTC Drugs Revenue, 2024-2029
6.2.3 By Region - Global Gastrointestinal OTC Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Gastrointestinal OTC Drugs Sales & Forecasts
6.3.1 By Region - Global Gastrointestinal OTC Drugs Sales, 2018-2023
6.3.2 By Region - Global Gastrointestinal OTC Drugs Sales, 2024-2029
6.3.3 By Region - Global Gastrointestinal OTC Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Gastrointestinal OTC Drugs Revenue, 2018-2029
6.4.2 By Country - North America Gastrointestinal OTC Drugs Sales, 2018-2029
6.4.3 US Gastrointestinal OTC Drugs Market Size, 2018-2029
6.4.4 Canada Gastrointestinal OTC Drugs Market Size, 2018-2029
6.4.5 Mexico Gastrointestinal OTC Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Gastrointestinal OTC Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Gastrointestinal OTC Drugs Sales, 2018-2029
6.5.3 Germany Gastrointestinal OTC Drugs Market Size, 2018-2029
6.5.4 France Gastrointestinal OTC Drugs Market Size, 2018-2029
6.5.5 U.K. Gastrointestinal OTC Drugs Market Size, 2018-2029
6.5.6 Italy Gastrointestinal OTC Drugs Market Size, 2018-2029
6.5.7 Russia Gastrointestinal OTC Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Gastrointestinal OTC Drugs Market Size, 2018-2029
6.5.9 Benelux Gastrointestinal OTC Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Gastrointestinal OTC Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Gastrointestinal OTC Drugs Sales, 2018-2029
6.6.3 China Gastrointestinal OTC Drugs Market Size, 2018-2029
6.6.4 Japan Gastrointestinal OTC Drugs Market Size, 2018-2029
6.6.5 South Korea Gastrointestinal OTC Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Gastrointestinal OTC Drugs Market Size, 2018-2029
6.6.7 India Gastrointestinal OTC Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Gastrointestinal OTC Drugs Revenue, 2018-2029
6.7.2 By Country - South America Gastrointestinal OTC Drugs Sales, 2018-2029
6.7.3 Brazil Gastrointestinal OTC Drugs Market Size, 2018-2029
6.7.4 Argentina Gastrointestinal OTC Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gastrointestinal OTC Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Gastrointestinal OTC Drugs Sales, 2018-2029
6.8.3 Turkey Gastrointestinal OTC Drugs Market Size, 2018-2029
6.8.4 Israel Gastrointestinal OTC Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Gastrointestinal OTC Drugs Market Size, 2018-2029
6.8.6 UAE Gastrointestinal OTC Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Gastrointestinal OTC Drugs Major Product Offerings
7.2.4 Pfizer Gastrointestinal OTC Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Major Product Offerings
7.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Gastrointestinal OTC Drugs Major Product Offerings
7.4.4 Bayer Gastrointestinal OTC Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 Procter & Gamble
7.5.1 Procter & Gamble Company Summary
7.5.2 Procter & Gamble Business Overview
7.5.3 Procter & Gamble Gastrointestinal OTC Drugs Major Product Offerings
7.5.4 Procter & Gamble Gastrointestinal OTC Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Procter & Gamble Key News & Latest Developments
7.6 Perrigo
7.6.1 Perrigo Company Summary
7.6.2 Perrigo Business Overview
7.6.3 Perrigo Gastrointestinal OTC Drugs Major Product Offerings
7.6.4 Perrigo Gastrointestinal OTC Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Perrigo Key News & Latest Developments
7.7 Abbott
7.7.1 Abbott Company Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Gastrointestinal OTC Drugs Major Product Offerings
7.7.4 Abbott Gastrointestinal OTC Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Abbott Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Gastrointestinal OTC Drugs Major Product Offerings
7.8.4 Sanofi Gastrointestinal OTC Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Company Summary
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Major Product Offerings
7.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Teva Pharmaceutical Key News & Latest Developments
7.10 Nestle
7.10.1 Nestle Company Summary
7.10.2 Nestle Business Overview
7.10.3 Nestle Gastrointestinal OTC Drugs Major Product Offerings
7.10.4 Nestle Gastrointestinal OTC Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Nestle Key News & Latest Developments
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Company Summary
7.11.2 Boehringer Ingelheim Gastrointestinal OTC Drugs Business Overview
7.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Major Product Offerings
7.11.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Boehringer Ingelheim Key News & Latest Developments
7.12 Reckitt Benckiser
7.12.1 Reckitt Benckiser Company Summary
7.12.2 Reckitt Benckiser Gastrointestinal OTC Drugs Business Overview
7.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Major Product Offerings
7.12.4 Reckitt Benckiser Gastrointestinal OTC Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Reckitt Benckiser Key News & Latest Developments
7.13 Purdue Pharma
7.13.1 Purdue Pharma Company Summary
7.13.2 Purdue Pharma Gastrointestinal OTC Drugs Business Overview
7.13.3 Purdue Pharma Gastrointestinal OTC Drugs Major Product Offerings
7.13.4 Purdue Pharma Gastrointestinal OTC Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Purdue Pharma Key News & Latest Developments
8 Global Gastrointestinal OTC Drugs Production Capacity, Analysis
8.1 Global Gastrointestinal OTC Drugs Production Capacity, 2018-2029
8.2 Gastrointestinal OTC Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastrointestinal OTC Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastrointestinal OTC Drugs Supply Chain Analysis
10.1 Gastrointestinal OTC Drugs Industry Value Chain
10.2 Gastrointestinal OTC Drugs Upstream Market
10.3 Gastrointestinal OTC Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastrointestinal OTC Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Gastrointestinal OTC Drugs in Global Market
Table 2. Top Gastrointestinal OTC Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Gastrointestinal OTC Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Gastrointestinal OTC Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Gastrointestinal OTC Drugs Sales by Companies, (K Dose), 2018-2023
Table 6. Global Gastrointestinal OTC Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Gastrointestinal OTC Drugs Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Gastrointestinal OTC Drugs Product Type
Table 9. List of Global Tier 1 Gastrointestinal OTC Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastrointestinal OTC Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Gastrointestinal OTC Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Gastrointestinal OTC Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Gastrointestinal OTC Drugs Sales (K Dose), 2018-2023
Table 15. By Type - Global Gastrointestinal OTC Drugs Sales (K Dose), 2024-2029
Table 16. By Application ? Global Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Gastrointestinal OTC Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Gastrointestinal OTC Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Gastrointestinal OTC Drugs Sales (K Dose), 2018-2023
Table 20. By Application - Global Gastrointestinal OTC Drugs Sales (K Dose), 2024-2029
Table 21. By Region ? Global Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Gastrointestinal OTC Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Gastrointestinal OTC Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Gastrointestinal OTC Drugs Sales (K Dose), 2018-2023
Table 25. By Region - Global Gastrointestinal OTC Drugs Sales (K Dose), 2024-2029
Table 26. By Country - North America Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Gastrointestinal OTC Drugs Sales, (K Dose), 2018-2023
Table 29. By Country - North America Gastrointestinal OTC Drugs Sales, (K Dose), 2024-2029
Table 30. By Country - Europe Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Gastrointestinal OTC Drugs Sales, (K Dose), 2018-2023
Table 33. By Country - Europe Gastrointestinal OTC Drugs Sales, (K Dose), 2024-2029
Table 34. By Region - Asia Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Gastrointestinal OTC Drugs Sales, (K Dose), 2018-2023
Table 37. By Region - Asia Gastrointestinal OTC Drugs Sales, (K Dose), 2024-2029
Table 38. By Country - South America Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Gastrointestinal OTC Drugs Sales, (K Dose), 2018-2023
Table 41. By Country - South America Gastrointestinal OTC Drugs Sales, (K Dose), 2024-2029
Table 42. By Country - Middle East & Africa Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Gastrointestinal OTC Drugs Sales, (K Dose), 2018-2023
Table 45. By Country - Middle East & Africa Gastrointestinal OTC Drugs Sales, (K Dose), 2024-2029
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Gastrointestinal OTC Drugs Product Offerings
Table 48. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Gastrointestinal OTC Drugs Product Offerings
Table 52. Pfizer Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Gastrointestinal OTC Drugs Product Offerings
Table 56. Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. Bayer Company Summary
Table 59. Bayer Gastrointestinal OTC Drugs Product Offerings
Table 60. Bayer Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. Bayer Key News & Latest Developments
Table 62. Procter & Gamble Company Summary
Table 63. Procter & Gamble Gastrointestinal OTC Drugs Product Offerings
Table 64. Procter & Gamble Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. Procter & Gamble Key News & Latest Developments
Table 66. Perrigo Company Summary
Table 67. Perrigo Gastrointestinal OTC Drugs Product Offerings
Table 68. Perrigo Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. Perrigo Key News & Latest Developments
Table 70. Abbott Company Summary
Table 71. Abbott Gastrointestinal OTC Drugs Product Offerings
Table 72. Abbott Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. Abbott Key News & Latest Developments
Table 74. Sanofi Company Summary
Table 75. Sanofi Gastrointestinal OTC Drugs Product Offerings
Table 76. Sanofi Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 77. Sanofi Key News & Latest Developments
Table 78. Teva Pharmaceutical Company Summary
Table 79. Teva Pharmaceutical Gastrointestinal OTC Drugs Product Offerings
Table 80. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 81. Teva Pharmaceutical Key News & Latest Developments
Table 82. Nestle Company Summary
Table 83. Nestle Gastrointestinal OTC Drugs Product Offerings
Table 84. Nestle Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 85. Nestle Key News & Latest Developments
Table 86. Boehringer Ingelheim Company Summary
Table 87. Boehringer Ingelheim Gastrointestinal OTC Drugs Product Offerings
Table 88. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 89. Boehringer Ingelheim Key News & Latest Developments
Table 90. Reckitt Benckiser Company Summary
Table 91. Reckitt Benckiser Gastrointestinal OTC Drugs Product Offerings
Table 92. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 93. Reckitt Benckiser Key News & Latest Developments
Table 94. Purdue Pharma Company Summary
Table 95. Purdue Pharma Gastrointestinal OTC Drugs Product Offerings
Table 96. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 97. Purdue Pharma Key News & Latest Developments
Table 98. Gastrointestinal OTC Drugs Production Capacity (K Dose) of Key Manufacturers in Global Market, 2021-2023 (K Dose)
Table 99. Global Gastrointestinal OTC Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Gastrointestinal OTC Drugs Production by Region, 2018-2023 (K Dose)
Table 101. Global Gastrointestinal OTC Drugs Production by Region, 2024-2029 (K Dose)
Table 102. Gastrointestinal OTC Drugs Market Opportunities & Trends in Global Market
Table 103. Gastrointestinal OTC Drugs Market Drivers in Global Market
Table 104. Gastrointestinal OTC Drugs Market Restraints in Global Market
Table 105. Gastrointestinal OTC Drugs Raw Materials
Table 106. Gastrointestinal OTC Drugs Raw Materials Suppliers in Global Market
Table 107. Typical Gastrointestinal OTC Drugs Downstream
Table 108. Gastrointestinal OTC Drugs Downstream Clients in Global Market
Table 109. Gastrointestinal OTC Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gastrointestinal OTC Drugs Segment by Type in 2022
Figure 2. Gastrointestinal OTC Drugs Segment by Application in 2022
Figure 3. Global Gastrointestinal OTC Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gastrointestinal OTC Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gastrointestinal OTC Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Gastrointestinal OTC Drugs Sales in Global Market: 2018-2029 (K Dose)
Figure 8. The Top 3 and 5 Players Market Share by Gastrointestinal OTC Drugs Revenue in 2022
Figure 9. By Type - Global Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Gastrointestinal OTC Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Gastrointestinal OTC Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Gastrointestinal OTC Drugs Price (USD/Dose), 2018-2029
Figure 13. By Application - Global Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Gastrointestinal OTC Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Gastrointestinal OTC Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Gastrointestinal OTC Drugs Price (USD/Dose), 2018-2029
Figure 17. By Region - Global Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Gastrointestinal OTC Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Gastrointestinal OTC Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Gastrointestinal OTC Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Gastrointestinal OTC Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Gastrointestinal OTC Drugs Sales Market Share, 2018-2029
Figure 23. US Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Gastrointestinal OTC Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Gastrointestinal OTC Drugs Sales Market Share, 2018-2029
Figure 28. Germany Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Gastrointestinal OTC Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Gastrointestinal OTC Drugs Sales Market Share, 2018-2029
Figure 37. China Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Gastrointestinal OTC Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Gastrointestinal OTC Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Gastrointestinal OTC Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Gastrointestinal OTC Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Gastrointestinal OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Gastrointestinal OTC Drugs Production Capacity (K Dose), 2018-2029
Figure 53. The Percentage of Production Gastrointestinal OTC Drugs by Region, 2022 VS 2029
Figure 54. Gastrointestinal OTC Drugs Industry Value Chain
Figure 55. Marketing Channels
